MA39568A1 - Dérivé de macrolide de polyène - Google Patents

Dérivé de macrolide de polyène

Info

Publication number
MA39568A1
MA39568A1 MA39568A MA39568A MA39568A1 MA 39568 A1 MA39568 A1 MA 39568A1 MA 39568 A MA39568 A MA 39568A MA 39568 A MA39568 A MA 39568A MA 39568 A1 MA39568 A1 MA 39568A1
Authority
MA
Morocco
Prior art keywords
polyene macrolide
macrolide derivative
formula
derivative
polyene
Prior art date
Application number
MA39568A
Other languages
English (en)
Inventor
Keisuke Miyazaki
Kenji Takaya
Takafumi Ohara
Hideki Sugimoto
Manabu Fujitani
Yuki Ogata
Naoyuki Suzuki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of MA39568A1 publication Critical patent/MA39568A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne un dérivé d'amphotéricine b représenté par la formule (i). Dans ladite formule, chaque symbole est tel que défini dans la description.Le composé de l'invention, qui se caractérise en ce qu'il présente une structure d'urée, une structure cyclique, hydroxyalkyle ou monoalkylcarbamoyle substitué à la position 16 (x), présente une activité antifongique.
MA39568A 2014-06-12 2015-06-12 Dérivé de macrolide de polyène MA39568A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014121341 2014-06-12
PCT/JP2015/066976 WO2015190587A1 (fr) 2014-06-12 2015-06-12 Dérivé de macrolide de polyène

Publications (1)

Publication Number Publication Date
MA39568A1 true MA39568A1 (fr) 2017-09-29

Family

ID=54833670

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39568A MA39568A1 (fr) 2014-06-12 2015-06-12 Dérivé de macrolide de polyène

Country Status (16)

Country Link
US (2) US10246478B2 (fr)
EP (1) EP3156410A4 (fr)
JP (1) JP6601818B2 (fr)
KR (1) KR102106765B1 (fr)
CN (1) CN106414473B (fr)
AU (1) AU2015272398B2 (fr)
BR (1) BR112016028890A8 (fr)
CA (1) CA2951516C (fr)
EA (1) EA037093B1 (fr)
IL (1) IL249430B (fr)
MA (1) MA39568A1 (fr)
MX (1) MX378786B (fr)
PH (1) PH12016502357A1 (fr)
SG (1) SG11201610162XA (fr)
TW (1) TWI702223B (fr)
WO (1) WO2015190587A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016061437A1 (fr) 2014-10-17 2016-04-21 The Board Of Trustees Of The University Of Illinois Synthèse modulable de dérivés d'amphotéricine b à toxicité réduite
WO2016112260A1 (fr) * 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Synthèse concise de dérivés d'urée d'amphotéricine b
JP7240811B2 (ja) * 2015-04-15 2023-03-16 スファンガ セラピューティクス インコーポレイテッド アムホテリシンｂの誘導体
WO2017100171A1 (fr) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Composés antifongiques et procédés s'y rapportant
WO2018106571A1 (fr) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Composés antifongiques et procédés
CA3111565A1 (fr) * 2018-09-07 2020-03-12 The Board Of Trustees Of The University Of Illinois Derives de l'amphotericine b hybrides a toxicite reduite
EP4009985A4 (fr) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois Dérivés amides hybrides d'amphotéricine b
AU2021325676A1 (en) * 2020-08-10 2023-03-30 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B
CN111909226A (zh) * 2020-08-11 2020-11-10 深圳市儿童医院 一种葡萄糖酸修饰的两性霉素b衍生物及其用途
CN115536716B (zh) * 2021-06-29 2025-08-08 中国科学院上海药物研究所 两性霉素b半合成衍生物及其制备方法和用途
CN113773355B (zh) * 2021-08-23 2023-03-10 湖南省微生物研究院 一种多烯大环内酯类化合物及其制备方法和应用
WO2026008878A1 (fr) * 2024-07-04 2026-01-08 Algipharma As Conjugués oligomère de polyène-alginate antimycosiques

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
ZA807892B (en) 1979-12-24 1981-12-30 Dumex Ltd As Water soluble guanidine derivatives of polyene marcrolides and the esters thereof
JPS56123794A (en) * 1980-02-29 1981-09-29 Nippon Denso Co Ltd Load driving unit for vehicle
JPH024295A (ja) * 1988-06-22 1990-01-09 Toshiba Corp 医用画像診断装置
GB8829593D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
FR2654339B1 (fr) 1989-11-14 1994-10-28 Mayoly Spindler Laboratoires Nouveaux derives solubles et non toxiques des macrolides polyeniques basiques, leur preparation et leurs applications.
FR2683723B1 (fr) * 1991-11-14 1995-05-19 Mayoly Spindler Laboratoires Nouveaux medicaments antiviraux actifs sur le virus vih.
WO1993016090A1 (fr) * 1992-02-12 1993-08-19 Smithkline Beecham Plc Derive d'amphotericine b
GB9203476D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5606038A (en) 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
FR2776927B1 (fr) 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
EP1198755A2 (fr) 1999-08-02 2002-04-24 Glaxo Group Limited Procedes informatises permettant d'estimer les couts et avantages relatifs aux interventions de gestion therapeutique
WO2001051061A1 (fr) 2000-01-14 2001-07-19 Intrabiotics Pharmaceuticals, Inc. Derives de macrolides de polyene, preparation et utilisations correspondantes
WO2007096137A1 (fr) * 2006-02-23 2007-08-30 Eth Zurich Dérivés d'amphotéricine
JP2010534688A (ja) 2007-07-30 2010-11-11 上海医薬工業研究院 ポリエン類抗生物質ジエステル化合物
MX365184B (es) 2010-12-21 2019-05-21 Centro De Investig Y De Estudios Avanzados Del I P N Nuevos compuestos analogos de la anfotericina y composiciones farmaceuticas que los contienen.
KR20150027217A (ko) * 2012-06-15 2015-03-11 블러트 에스.에이. 항진균성 항생 암포테리신 b의 n-치환된 제2 세대 유도체, 및 이의 제조 및 응용 방법
KR102548341B1 (ko) * 2013-10-07 2023-06-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 개선된 치료 지수를 갖는 암포테리신 b 유도체
WO2016112243A1 (fr) 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Dérivés d'urée de l'amphotéricine b dérivée d'amines secondaires
JP7240811B2 (ja) 2015-04-15 2023-03-16 スファンガ セラピューティクス インコーポレイテッド アムホテリシンｂの誘導体

Also Published As

Publication number Publication date
IL249430B (en) 2020-05-31
US10696707B2 (en) 2020-06-30
CN106414473A (zh) 2017-02-15
EA201692508A1 (ru) 2017-04-28
JPWO2015190587A1 (ja) 2017-04-20
JP6601818B2 (ja) 2019-11-06
BR112016028890A8 (pt) 2021-03-23
AU2015272398A1 (en) 2016-12-08
EP3156410A4 (fr) 2018-01-03
TW201625655A (zh) 2016-07-16
US20170190729A1 (en) 2017-07-06
CA2951516A1 (fr) 2015-12-17
EA037093B1 (ru) 2021-02-04
AU2015272398B2 (en) 2018-04-26
PH12016502357A1 (en) 2017-02-13
SG11201610162XA (en) 2017-01-27
BR112016028890A2 (pt) 2017-08-22
WO2015190587A1 (fr) 2015-12-17
KR102106765B1 (ko) 2020-05-06
CA2951516C (fr) 2019-04-02
KR20170016957A (ko) 2017-02-14
CN106414473B (zh) 2020-03-13
MX378786B (es) 2025-03-11
MX2016015455A (es) 2017-03-23
US20190135847A1 (en) 2019-05-09
IL249430A0 (en) 2017-02-28
TWI702223B (zh) 2020-08-21
US10246478B2 (en) 2019-04-02
EP3156410A1 (fr) 2017-04-19

Similar Documents

Publication Publication Date Title
MA39568A1 (fr) Dérivé de macrolide de polyène
SI3577110T1 (sl) 8-oksetan-3-IL-3,8-diazabiciklo(3.2.1)oktan-3-IL substituirane spojine kot zaviralci HIV-a
MA47433A (fr) Composé de quinazoline
BR112018010118A2 (pt) inibidores de cxcr2
EA201790064A1 (ru) Пестицидные композиции
MA38390B1 (fr) Composés tétrahydropyrrolothiazines
EP3515927A4 (fr) Composé fluorescent comprenant un fluorophore conjugué à un polypeptide déclenché par ph
EP4186903A4 (fr) Composé quinazoline
EP3578555A4 (fr) Composé de diphénylaminopyrimidine inhibant l'activité kinase
EP4286378A4 (fr) Composé pyrimidopyrane
LT3672965T (lt) Pirimidino junginys, kaip jak kinazės inhibitorius
EA201891278A1 (ru) Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа
EP4050009A4 (fr) Composé à petites molécules
EP3789383A4 (fr) Composé de benzisoxazole
EP3786169A4 (fr) Composé rotaxane
UA120058C2 (uk) Пестицидні композиції
EA201892449A1 (ru) Конденсированные гетероциклические соединения
EP3778573A4 (fr) Composé présentant une activité anticancéreuse
AR097253A1 (es) Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida
BR112018008006A2 (pt) composto de piranodipiridina
SV2019005838A (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana
EP3725795A4 (fr) Composé marqué par un isotope stable
EP3505170A4 (fr) Préparation ophtalmique comprenant un composé azole
EA201991655A1 (ru) Тиобензоимидазолы в качестве фунгицидов
EP3506757A4 (fr) Composés de pyrido-1,3-oxazine-2,4-dione à activité fongicide